Diagnostic accuracy of exhaled nitric oxide for the non-invasive identification of patients with fibrotic metabolic dysfunction-associated steatohepatitis
Sign Up to like & getrecommendations! Published in 2024 at "Annals of Medicine"
DOI: 10.1080/07853890.2024.2410408
Abstract: Abstract Background Fibrotic metabolic dysfunction-associated steatohepatitis (MASH) is a condition at risk of progressing to advanced liver disease. We examined whether an innovative exhaled nitric oxide (eNO) breath test (BT) can accurately diagnose fibrotic MASH… read more here.
Keywords: fibrotic mash; dysfunction associated; fibrotic metabolic; associated steatohepatitis ... See more keywords
Proton density fat fraction for diagnosis of metabolic dysfunction associated steatotic liver disease.
Sign Up to like & getrecommendations! Published in 2025 at "Hepatology"
DOI: 10.1097/hep.0000000000001318
Abstract: BACKGROUND AIMS Prior work has shown that magnetic resonance imaging (MRI)-derived proton density fat fraction (PDFF) can diagnose metabolic dysfunction-associated steatotic liver disease (MASLD) noninvasively, but there is a paucity of data on the performance… read more here.
Keywords: pdff; fibrotic mash; dysfunction associated; mash ... See more keywords